#sarcopenic obesity
Discover 3 curated intelligence briefings related to this specific topic.
The Metabolic Pivot: GLP-1s and the Quest for Biological Youth
The conversation around GLP-1 receptor agonists has shifted from rapid weight loss to the 'longevity stack.' By combining these medications with precise nutritional and strength protocols, practitioners are now targeting 'metabolic age' to extend healthspan, moving far beyond simple calorie restriction.
The Lean Mass Paradox: Inside the Race to Save Muscle in the GLP-1 Era
The gold rush of GLP-1 agonists has delivered unprecedented weight loss, but at a hidden cost. We investigate the 'Muscle Gap' and the pharmaceutical pivot toward muscle-sparing therapies to prevent a global surge in iatrogenic sarcopenia.
The Muscle Preservation Protocol: Safeguarding Lean Mass in the Era of GLP-1s
Rapid weight loss via GLP-1 agonists often hides a dangerous secret: significant lean muscle loss. This guide provides a clinical-grade protocol to preserve metabolic health, maintain strength, and ensure weight loss comes from fat, not functional tissue.